 | Issue navigator |
|
|
Contents of Volume 5 Suppl 1
24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models
Meeting abstracts
Sacramento, USA. 1-5 November 2003
|
Oral presentation
Mouse models of human breast cancer: evolution or convolution?
JE Green
Breast Cancer Res 2003, 5(Suppl 1):1 (31 October 2003)
[Full text] [PDF]
Oral presentation
Estrogen receptor alpha-positive and negative mouse mammary tumors through somatic mutations of p53 in mammary carcinogenesis
S-CJ Lin, K-F Lee, AY Nikitin, KM Bushnell, SG Hilsenbeck, RD Cardiff, A Li, K-W Kang, SA Frank, W-H Lee, EY-HP Lee
Breast Cancer Res 2003, 5(Suppl 1):2 (31 October 2003)
[Full text] [PDF]
Oral presentation
Mouse models for BRCA1-associated breast cancer
R-H Wang, W Li, X Xu, C Deng
Breast Cancer Res 2003, 5(Suppl 1):3 (31 October 2003)
[Full text] [PDF]
Oral presentation
Integrin-mediated signal transduction in transgenic mouse models of human breast cancer
DE White, S Blaess, U Mueller, S Dedhar, RD Cardiff, R St Arnaud, WJ Muller
Breast Cancer Res 2003, 5(Suppl 1):4 (31 October 2003)
[Full text] [PDF]
Oral presentation
Reversibility and progression in conditional transgenic mouse models of breast cancer
LA Chodosh, RB Boxer, SE Moody, BA Keister, CJ Sarkisian, JW Jang, GK Belka, CM Blakely, CP Portocarero, CJ Sterner, KL Notarfrancesco, EA Kauh
Breast Cancer Res 2003, 5(Suppl 1):5 (31 October 2003)
[Full text] [PDF]
Oral presentation
Genetic manipulation of the mammary gland by transplantation
P Edwards
Breast Cancer Res 2003, 5(Suppl 1):6 (31 October 2003)
[Full text] [PDF]
Oral presentation
The Mutant Mouse Regional Resource Center Program
KCK Lloyd
Breast Cancer Res 2003, 5(Suppl 1):7 (31 October 2003)
[Full text] [PDF]
Oral presentation
Genetically altered mice and cancer research: effects of the other 99.999% of the genome and other variables upon phenotype
SW Barthold
Breast Cancer Res 2003, 5(Suppl 1):8 (31 October 2003)
[Full text] [PDF]
Oral presentation
Advanced immunophenotyping: more is better!
N Baumgarth
Breast Cancer Res 2003, 5(Suppl 1):9 (31 October 2003)
[Full text] [PDF]
Oral presentation
Whole Slide Imaging and telepathology
J Galvez
Breast Cancer Res 2003, 5(Suppl 1):10 (31 October 2003)
[Full text] [PDF]
Oral presentation
Mammary pathology of the genetically engineered mouse
AD Borowsky
Breast Cancer Res 2003, 5(Suppl 1):11 (31 October 2003)
[Full text] [PDF]
Oral presentation
Positron emission tomography and X-ray computed tomography: tools for mouse phenotyping?
SR Cherry
Breast Cancer Res 2003, 5(Suppl 1):12 (31 October 2003)
[Full text] [PDF]
Oral presentation
Genetically modified cancer models: the value of luciferase-tagged tumors and in vivo luciferase-based reporter assays in oncology drug discovery
W Yang, C Kowal, E Sorensen, P Lassota
Breast Cancer Res 2003, 5(Suppl 1):13 (31 October 2003)
[Full text] [PDF]
Oral presentation
Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
RH Schwall, P Hollingshead, S Erickson, J Winer, M Williams, D Dugger
Breast Cancer Res 2003, 5(Suppl 1):14 (31 October 2003)
[Full text] [PDF]
Oral presentation
Role of animal models in oncology drug discovery
R Kumar
Breast Cancer Res 2003, 5(Suppl 1):15 (31 October 2003)
[Full text] [PDF]
Oral presentation
Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
LM Wakefield, Y Yang, O Dukhanina, B Tang, M Mamura, JL Letterio, J Green, GT Merlino, MR Anver
Breast Cancer Res 2003, 5(Suppl 1):16 (31 October 2003)
[Full text] [PDF]
Oral presentation
Development of a transgenic mouse line for the evaluation of the androgen receptor activity in vivo
R Attar, C Cullinan, C-P Ho, M Swerdel, J Dell, RB Rowley, DJ Bol, J Ostrowski, K Mookhtiar, M Gottardis, R Weinmann
Breast Cancer Res 2003, 5(Suppl 1):17 (31 October 2003)
[Full text] [PDF]
Oral presentation
Clinical breast cancer and estrogen
HK Chew
Breast Cancer Res 2003, 5(Suppl 1):18 (31 October 2003)
[Full text] [PDF]
Oral presentation
Pregnancy levels of estrogen prevents breast cancer
S Nandi, RC Guzman, G Thordarson, L Rajkumar
Breast Cancer Res 2003, 5(Suppl 1):19 (31 October 2003)
[Full text] [PDF]
Oral presentation
Steroid regulation of breast cancer cell proliferation
RL Sutherland
Breast Cancer Res 2003, 5(Suppl 1):20 (31 October 2003)
[Full text] [PDF]
| |
|  |
